← Eichor
Condition: Tumor Grade Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tumor Grade

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Using Consumer-grade Wearable Devices for Fall Risk Evaluation and Alerts
Phase N/A · 1 location(s) · University of Michigan · NCT06508892Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
NA · 1 location(s) · University of California, San Francisco · NCT07506239A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Phase 3 · 106 location(s) · Verastem, Inc. · NCT06072781CapTemY90 for Grade 2/3 NET Liver Metastases
Phase 2 · 4 location(s) · Abramson Cancer Center at Penn Medicine · NCT04339036Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Phase 1 · 1 location(s) · Beijing Biotech · NCT07480941Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing
NA · 3 location(s) · Reprise Biomedical, Inc. · NCT06939686Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular Lymphoma
Phase 2 · 1 location(s) · Evopoint Biosciences Inc. · NCT07545603Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04712851[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma
EARLY_Phase 1 · 2 location(s) · Beijing Tiantan Hospital · NCT07655869A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG
Phase 2 · 1 location(s) · Henan Cancer Hospital · NCT06774222CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors
Phase N/A · 1 location(s) · European Institute of Oncology · NCT07429851Vorasidenib Maintenance for IDH Mutant Astrocytoma
Phase 3 · 33 location(s) · European Organisation for Research and Treatment of Cancer - · NCT06809322Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
Phase 1 · 27 location(s) · National Cancer Institute (NCI) · NCT04633239Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functi
NA · 1 location(s) · University of Washington · NCT06710418Chemoablation for Low-Grade Bladder Cancer
Phase 2 · 1 location(s) · Ekaterina Laukhtina · NCT07019220Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
EARLY_Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT05555550Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cance
Phase 2 · 1 location(s) · Bai-Rong Xia · NCT07125391Pregabalin Phonophoresis and MET for Knee Osteoarthritis
NA · 1 location(s) · University of Faisalabad · NCT07598474A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · 62 location(s) · UroGen Pharma Ltd. · NCT06774131Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group
Phase N/A · 10 location(s) · IRCCS San Raffaele · NCT04945603Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
Phase 1 · 1 location(s) · Theolytics Limited · NCT07211659Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B C
Phase 1/Phase 2 · 1 location(s) · OHSU Knight Cancer Institute · NCT06249191A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · 202 location(s) · National Cancer Institute (NCI) · NCT05691478Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 13 location(s) · Exscientia AI Ltd., a wholly owned subsidiary of Recursion P · NCT05985655MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Phase 3 · 53 location(s) · Swiss GO Trial Group · NCT04111978Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma
Phase 2 · 1 location(s) · Chinese PLA General Hospital · NCT06471738A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Phase 3 · 132 location(s) · National Cancer Institute (NCI) · NCT041664095G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
Phase 1/Phase 2 · 3 location(s) · Institute of Cancer Research, United Kingdom · NCT06630260Prediction of Intraventricular Hemorrhage Using Echocardiography and Near Infrared Spectroscopy
Phase N/A · 4 location(s) · Mount Sinai Hospital, Canada · NCT05708105STARLITE for Unresectable High-Grade Gliomas
Phase 1 · 1 location(s) · University of Miami · NCT06428045
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.